Concepedia

James R. Tata

JR

Statistics

Publications

77

Citations

3.2K

H-Index

31

Active since

1986

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Arena Pharmaceuticals (United States)

James R. Tata is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicinal chemistry, and drug discovery.

ORCID

Publications per year

1986–2022

77

Publications

77

Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue.

Arthur A. Patchett, Ravi P. Nargund, James R. Tata et al. · Proceedings of the National Academy of Sciences · 1995 · 331 citations

, , +11

The First Stereoselective Total Synthesis of Quinine

Gilbert Stork, Deqiang Niu, Azumi Fujimoto et al. · Journal of the American Chemical Society · 2001 · 208 citations

, , +5

Discovery of MK-1454: A Potent Cyclic Dinucleotide Stimulator of Interferon Genes Agonist for the Treatment of Cancer

Wonsuk Chang, Michael D. Altman, Charles A. Lesburg et al. · Journal of Medicinal Chemistry · 2022 · 137 citations · Full text

, , +17

Niacin Lipid Efficacy Is Independent of Both the Niacin Receptor GPR109A and Free Fatty Acid Suppression

Brett Lauring, Andrew K.P. Taggart, James R. Tata et al. · Science Translational Medicine · 2012 · 127 citations

, , +8

Structural Requirements for the Activation of the Human Growth Hormone Secretagogue Receptor by Peptide and Nonpeptide Secretagogues

Scott D. Feighner, Andrew Howard, Kristine Prendergast et al. · Molecular Endocrinology · 1998 · 125 citations · Full text

, , +17

1–5 of 77